期刊文献+

Efficacy and safety of puerarin injection in treatment of diabetic peripheral neuropathy: a systematic review and Meta-analysis of randomized controlled trials 被引量:25

Efficacy and safety of puerarin injection in treatment of diabetic peripheral neuropathy: a systematic review and Meta-analysis of randomized controlled trials
原文传递
导出
摘要 OBJECTIVE: To systematically evaluate the clinical efficacy and safety of puerarin injection in the treatment of diabeticperi pheral neuropathy(DPN).METHODS: Randomized controlled trials investigating the efficacy of puerarin injection on DPN were searched for in China National Knowledge Infrastructure Database, Chinese Scientific Journals Database, Wanfang Database, Chinese Biomedical Literature Database, PubMed, and Cochrane Library from establishment to April 30.Two reviewers independently retrieved and extracted the information.The included studies were assessed by the Cochrane risk of bias and analyzed by Review Manager 5.2 software.RESULTS: Twenty-two studies involving 1664 participants were included. The quality of the studies was found to be relatively low. Meta-analysis showed that puerarin injection combined with western medication was more effective than conventional therapy for rate, nerve conduction velocity(NCV), and hemorheology index. Six adverse drug reactions(ADRs) from puerarin injection were reported in two studies. Reactions included facial flushing, palpitations, and pain at infusion locations. However,noserious ADRs were reported.CONCLUSION: Puerarin injection was effective for the treatment of DPN. Puerarin can improve the total effective rate, correct NCV that was decreased by diabetes, and improve the hemorheology index.Puerarin was also relatively safe clinically. However,since the articles included in the study were not high-quality, more studies should be conducted to strengthen their findings. OBJECTIVE: To systematically evaluate the clinical efficacy and safety of puerarin injection in the treatment of diabeticperi pheral neuropathy(DPN).METHODS: Randomized controlled trials investigating the efficacy of puerarin injection on DPN were searched for in China National Knowledge Infrastructure Database, Chinese Scientific Journals Database, Wanfang Database, Chinese Biomedical Literature Database, PubMed, and Cochrane Library from establishment to April 30.Two reviewers independently retrieved and extracted the information.The included studies were assessed by the Cochrane risk of bias and analyzed by Review Manager 5.2 software.RESULTS: Twenty-two studies involving 1664 participants were included. The quality of the studies was found to be relatively low. Meta-analysis showed that puerarin injection combined with western medication was more effective than conventional therapy for rate, nerve conduction velocity(NCV), and hemorheology index. Six adverse drug reactions(ADRs) from puerarin injection were reported in two studies. Reactions included facial flushing, palpitations, and pain at infusion locations. However,noserious ADRs were reported.CONCLUSION: Puerarin injection was effective for the treatment of DPN. Puerarin can improve the total effective rate, correct NCV that was decreased by diabetes, and improve the hemorheology index.Puerarin was also relatively safe clinically. However,since the articles included in the study were not high-quality, more studies should be conducted to strengthen their findings.
出处 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2014年第4期401-410,共10页 中医杂志(英文版)
基金 Supported by Detection Technology Procedures and Normative Research of Priority Species of TCM of National Science and Technology Support Program(No.2006BAI21B11) Scientific Research Innovation Team Project of Beijing University of Chinese Medicine(No.2011-CXTD-14) Postgraduate Independent Topics(No.2014-JYBZZ-XS-078)
关键词 Puerarin Diabetic neuropathies Treatment outcome Meta-analysis Randomized controlledtrials 随机对照试验 西药治疗 周围神经 葛根素 注射液 糖尿病 安全性 病变
  • 相关文献

参考文献2

二级参考文献30

  • 1王晓青,傅静.葛根的药理作用研究进展(综述)[J].北京中医药大学学报,1994,17(3):39-41. 被引量:81
  • 2张家庆,周云平.部分中药或其成分对大鼠晶体醛糖还原酶的抑制作用[J].中国中药杂志,1989,14(9):45-47. 被引量:104
  • 3钱肇仁 钟学礼.糖尿病神经病变[J].上海医学,1984,7(7):426-426.
  • 4李淑娥 何绥平.普乐林引起过敏反应5例[J].药物流行病学杂志,1997,6(4):251-251.
  • 5[4]Brown lee M. Glycafion and diabetic complications[ J]. Diabetes, 1994,43: 836.
  • 6Hotta N, Toyta T, Matsuoka K, Shingeta Y, Kikkawa R,Kaneko T, Takahashi A, Sugimura K, Koike Y, Ishii J,Sakamoto N. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy[J]. Diabetes Care, 2001; 24(10): 1
  • 7Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR,Giuliani MJ, Kincaid JC, Ochoa JL, Parry GJ, Weimer LH.Quantitative sensory testing. Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology [J]. Neurology,
  • 8Diabetes Control and Complication Trial Research Group.The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in InsulinDependent Diabetes Mellitus [ J ]. N Engl J Med , 1993; 329(14): 977 -986
  • 9D. Ziegler. The design of trials for treatment of diabetic neuropathy[J]. Neuropathy Res Commun, 1997 ; 21 ( 1 ): 83 -91
  • 10Pfeifer MA, Schumer MP. Clinical trials of diabetic neuropathy: past, present and future[J]. Diabetes, 1995; 44(12) :1 355-1 361

共引文献9

同被引文献396

引证文献25

二级引证文献276

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部